Anti-TWEAK
Produktgrößen
100 ug
£662,00
OAED00375-100UG
Über dieses Produkt
- SKU:
- OAED00375
- Zusätzliche Namen:
- APO3 ligand;APO3/DR3 ligand;APO3L;DR3LG;TNF-related WEAK inducer of apoptosis;TNFSF12-TNFSF13 protein;TNLG4A;tumor necrosis factor (ligand) superfamily; member 12;tumor necrosis factor (ligand) superfamily; member 12-member 13;tumor necrosis factor ligand 4A;tumor necrosis factor ligand superfamily member 12;tumor necrosis factor superfamily member 12;TWEAK;TWE-PRIL.
- translate.label.attr.clone:
- Mira-2
- Klonalität:
- Monoclonal
- Konzentration:
- 1mg/ml
- Weitere Details:
- Binds to FN14 and possibly also to TNRFSF12/APO3. Weak inducer of apoptosis in some cell types. Mediates NF-kappa-B activation. Promotes angiogenesis and the proliferation of endothelial cells. Also involved in induction of inflammatory cytokines. Promotes IL8 secretion.
- Gendetails:
- TNF superfamily member 12|TNFSF12-TNFSF13 readthrough
- Host:
- Mouse
- Immunogen:
- Recombinant human TWEAK extracellular domain (aa 106-249) (Prod. No. ALX-522-021).
- Isotyp:
- IgG1
- Proteindetails:
- Tumor necrosis factor ligand superfamily member 12
- Reinheit:
- Protein G-affinity purified.<br/>≥95% (SDS-PAGE)
- Versandbedingungen:
- Blue Ice
- Quelle:
- Purified from concentrated hybridoma tissue culture supernatant.
- Lagerbedingungen:
- Long Term Storage : -20C
Short Term Storage : +4C
Handling : After opening; prepare aliquots and store at -20C.
Avoid freeze/thaw cycles
Stable for at least 1 year after receipt when stored at -20C. - Hersteller:
- Aviva Systems Biology
- Typ:
- Antibodies: Monoclonal Antibody
- Datenblatt des Herstellers:html_datasheet.php